Rozlany chłoniak z dużych komórek B: badanie fazy II/III leku gemcitabine i bendamustine hydrochloride
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)